Live Breaking News & Updates on Placebo Controlled Multicenter Study

Stay updated with breaking news from Placebo controlled multicenter study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

CAL02 is a unique therapeutic agent that is designed to work differently from antibiotics, aiming to disarm an infectious pathogen’s virulence factors to reduce damage and mitigate disease . ....

United States , Lisam Wilson , Valentin Curt , Eagle Pharmaceuticals , Globenewswire Inc , Eagle Pharmaceuticals Inc , Site Communications Inc , Severe Community , Drug Administration , Company Annual Report On Form , Clinical Drug Development , Acacia Pharma Inc , Company Quarterly Report On Form , American Society For Microbiology , Exchange Commission , European Society For Clinical Microbiology , European Medicines Agency , Clinical Microbiology , Infectious Diseases , Senior Vice President , Interim Chief Medical Officer , Placebo Controlled Multicenter Study , Severe Community Acquired Bacterial Pneumonia , Qualified Infectious Disease Product , Fast Track Designation , Patent Term Extension ,